Cita APA

Fuchs, B. C., Hoshida, Y., & Tanabe, K. K. (2014). Reply: Erlotinib might be a double-edged sword in HCC. Hepatology.

Citación estilo Chicago

Fuchs, Bryan C., Yujin Hoshida, y Kenneth K. Tanabe. "Reply: Erlotinib Might Be a Double-edged Sword in HCC." Hepatology 2014.

Cita MLA

Fuchs, Bryan C., Yujin Hoshida, y Kenneth K. Tanabe. "Reply: Erlotinib Might Be a Double-edged Sword in HCC." Hepatology 2014.